TRIANA Biomedicines, Inc : TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer
bostonstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonstar.com Daily Mail and Mail on Sunday newspapers.
(0)
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / April 21, 2021 / At today s AGM of Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, the shareholders of the company approved all motions proposed by the Board of Directors with a very large majority.
In light of the current COVID-19 situation and in line with the applicable Swiss regulation, this year s Annual General Meeting was conducted solely by voting through the independent proxy and without physical attendance of shareholders.
The shareholders of the company elected Agnete Fredriksen and Dominik Höchli as new members of the Board of Directors of Molecular Partners. Both new board members were determined to be independent and add deep scientific and business expertise in immunotherapy, oncology and infectious disease as well as extensive know-how in clinical affairs and marketing to the company, respectively.
Shareholders of Molecular Partners AG Approve all Board Proposals at the Annual General Meeting; Agnete Fredriksen and Dominik Höchli Elected New Board Members
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.